LONG BEACH, Calif. / Sep 04, 2024 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that Senior Executive Vice President and Chief Financial Officer, Mark Keim, will assume an expanded role which will now include leadership of the Company’s Medicaid Health Plans and Marketplace business. His responsibilities as Chief Financial Officer of the enterprise remain unchanged.
Keim, 59, joined Molina in January of 2018 and was named Chief Financial Officer in February 2021.
“Mark has been an extraordinary leader not only in the realm of finance, but also in strategic development and operations," said Molina President and CEO Joe Zubretsky. “Formally extending that leadership and results orientation to our Medicaid and Marketplace businesses is a natural evolution. Mark and Chief Operating Officer Jim Woys lead a very talented and deep operating team which has been the hallmark of our success.”
About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com.
| Last Trade: | US$294.73 |
| Daily Change: | 1.21 0.41 |
| Daily Volume: | 1,161,132 |
| Market Cap: | US$16.860B |
November 18, 2024 October 23, 2024 October 16, 2024 July 23, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
